Skip to main content
Top
Published in: Lasers in Medical Science 2/2022

01-03-2022 | Photodynamic Therapy | Original Article

Combination of cisplatin treatment and photodynamic therapy attenuates cisplatin-induced cell toxicity in A2780 and A2780-CP cervical cancer cell lines

Authors: Fatemeh Javani Jouni, Vahideh Abdollahi, Shahrzad Zadehmodarres, Hossein Abbasinia, Mohammad Asnaashari, Jaber Zafari

Published in: Lasers in Medical Science | Issue 2/2022

Login to get access

Abstract

Cervical cancer is recognized as a serious worldwide health problem. Despite various achievements for cervical cancer treatment, there are still shortcomings that lead to severe side effects. Combination therapy is fast becoming a key and promising treatment strategy, diminishing chemotherapy-mediated side effects. The objective of this study was to determine the effect of combined cisplatin treatment and photodynamic therapy (PDT) on the cervical cancer recovery. In this study, A2780 and A2780-CP cell lines were cultured in the Dulbecco’s modified eagle medium (DMEM) enriched with 10% FBS and 1% antibiotic. Both cell lines were treated with cisplatin, photodynamic light (laser with methylene blue as a photosensitizer agent), and the combination of cisplatin treatment and PDT. Half maximum inhibitory concentration (IC50) was calculated for each treatment by the use of tetrazolium salt assay. Both cell lines were examined for cell membrane lipid peroxidation rate. Our findings showed that combination of cisplatin treatment and photodynamic therapy leads to two-fold decreased cisplatin IC50. Results showed that cisplatin and photodynamic light combination could effectively reduce A2780 and A2780-CP cell viability (p-value < 0.0001). Moreover, combined cisplatin and photodynamic therapy results revealed significantly increased cancer cell membrane destruction through increased lipid peroxidation, resulting in surged MDA content. Our conclusion is that combination of cisplatin and photodynamic therapy can be used as an effective and convenient treatment strategy without considerable side effects.
Literature
1.
go back to reference Bray F et al (2020) Erratum: global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 70(4):313 Bray F et al (2020) Erratum: global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 70(4):313
2.
go back to reference Bedell SL et al (2020) Cervical cancer screening: past, present, and future. Sex Med Rev 8(1):28–37CrossRef Bedell SL et al (2020) Cervical cancer screening: past, present, and future. Sex Med Rev 8(1):28–37CrossRef
3.
go back to reference Ferlay J et al (2018) Global cancer observatory: cancer today. International Agency for Research on Cancer, Lyon Ferlay J et al (2018) Global cancer observatory: cancer today. International Agency for Research on Cancer, Lyon
4.
go back to reference Green JA et al (2005) Concomitant chemotherapy and radiation therapy for cancer of the uterine cervix. Cochrane Database System Rev 2(3):1–11 Green JA et al (2005) Concomitant chemotherapy and radiation therapy for cancer of the uterine cervix. Cochrane Database System Rev 2(3):1–11
5.
go back to reference Prestayko AW et al (1979) Cisplatin (cis-diamminedichloroplatinum II). Cancer Treat Rev 6(1):17–39CrossRef Prestayko AW et al (1979) Cisplatin (cis-diamminedichloroplatinum II). Cancer Treat Rev 6(1):17–39CrossRef
6.
go back to reference Lebwohl D, Canetta R (1998) Clinical development of platinum complexes in cancer therapy: an historical perspective and an update. Eur J Cancer 34(10):1522–1534CrossRef Lebwohl D, Canetta R (1998) Clinical development of platinum complexes in cancer therapy: an historical perspective and an update. Eur J Cancer 34(10):1522–1534CrossRef
7.
go back to reference Galanski M (2006) Recent developments in the field of anticancer platinum complexes. Recent Patents Anti Cancer Drug Discov 1(2):285–295CrossRef Galanski M (2006) Recent developments in the field of anticancer platinum complexes. Recent Patents Anti Cancer Drug Discov 1(2):285–295CrossRef
8.
go back to reference Oronsky B et al (2017) A brief review of the management of platinum-resistant–platinum-refractory ovarian cancer. Med Oncol 34(6):103CrossRef Oronsky B et al (2017) A brief review of the management of platinum-resistant–platinum-refractory ovarian cancer. Med Oncol 34(6):103CrossRef
9.
go back to reference Freimund AE et al (2018) Mechanisms of drug resistance in high-grade serous ovarian cancer. Hematol/Oncol Clin 32(6):983–996CrossRef Freimund AE et al (2018) Mechanisms of drug resistance in high-grade serous ovarian cancer. Hematol/Oncol Clin 32(6):983–996CrossRef
10.
go back to reference Meyer K, Madias N (1994) Cisplatin nephrotoxicity. Miner Electrolyte Metab 20(4):201–213PubMed Meyer K, Madias N (1994) Cisplatin nephrotoxicity. Miner Electrolyte Metab 20(4):201–213PubMed
11.
go back to reference Crul M et al (2002) DNA-based drug interactions of cisplatin. Cancer Treatment Rev 28(6):291–303CrossRef Crul M et al (2002) DNA-based drug interactions of cisplatin. Cancer Treatment Rev 28(6):291–303CrossRef
12.
go back to reference Rizvi I et al (2010) Synergistic enhancement of carboplatin efficacy with photodynamic therapy in a three-dimensional model for micrometastatic ovarian cancer. Cancer Res 70(22):9319–9328CrossRef Rizvi I et al (2010) Synergistic enhancement of carboplatin efficacy with photodynamic therapy in a three-dimensional model for micrometastatic ovarian cancer. Cancer Res 70(22):9319–9328CrossRef
13.
go back to reference Ahn T-G et al (2012) Photodynamic therapy for breast cancer in a BALB/c mouse model. J Gynecol Oncol 23(2):115CrossRef Ahn T-G et al (2012) Photodynamic therapy for breast cancer in a BALB/c mouse model. J Gynecol Oncol 23(2):115CrossRef
14.
go back to reference Montazerabadi A-R et al (2012) Mitoxantrone as a prospective photosensitizer for photodynamic therapy of breast cancer. Photodiagn Photodyn Ther 9(1):46–51CrossRef Montazerabadi A-R et al (2012) Mitoxantrone as a prospective photosensitizer for photodynamic therapy of breast cancer. Photodiagn Photodyn Ther 9(1):46–51CrossRef
15.
go back to reference Agostinis P et al (2004) Regulatory pathways in photodynamic therapy induced apoptosis. Photochem Photobiol Sci 3(8):721–729CrossRef Agostinis P et al (2004) Regulatory pathways in photodynamic therapy induced apoptosis. Photochem Photobiol Sci 3(8):721–729CrossRef
16.
go back to reference Casas A et al (2011) Mechanisms of resistance to photodynamic therapy. Curr Med Chem 18(16):2486–2515CrossRef Casas A et al (2011) Mechanisms of resistance to photodynamic therapy. Curr Med Chem 18(16):2486–2515CrossRef
18.
go back to reference Brown SB, Brown EA, Walker I (2004) The present and future role of photodynamic therapy in cancer treatment. Lancet Oncol 5(8):497–508CrossRef Brown SB, Brown EA, Walker I (2004) The present and future role of photodynamic therapy in cancer treatment. Lancet Oncol 5(8):497–508CrossRef
19.
go back to reference Sun L et al (2021) Assembled small organic molecules for photodynamic therapy and photothermal therapy. RSC Adv 11(17):10061–10074CrossRef Sun L et al (2021) Assembled small organic molecules for photodynamic therapy and photothermal therapy. RSC Adv 11(17):10061–10074CrossRef
20.
go back to reference Li X et al (2018) New application of phthalocyanine molecules: from photodynamic therapy to photothermal therapy by means of structural regulation rather than formation of aggregates. Chem Sci 9(8):2098–2104CrossRef Li X et al (2018) New application of phthalocyanine molecules: from photodynamic therapy to photothermal therapy by means of structural regulation rather than formation of aggregates. Chem Sci 9(8):2098–2104CrossRef
21.
go back to reference Canti G et al (1998) Antitumor efficacy of the combination of photodynamic therapy and chemotherapy in murine tumors. Cancer Lett 125(1–2):39–44CrossRef Canti G et al (1998) Antitumor efficacy of the combination of photodynamic therapy and chemotherapy in murine tumors. Cancer Lett 125(1–2):39–44CrossRef
22.
go back to reference Kelleher D et al (2003) Enhanced effects of aminolaevulinic acid-based photodynamic therapy through local hyperthermia in rat tumours. Br J Cancer 89(2):405–411CrossRef Kelleher D et al (2003) Enhanced effects of aminolaevulinic acid-based photodynamic therapy through local hyperthermia in rat tumours. Br J Cancer 89(2):405–411CrossRef
23.
go back to reference Barnard C (2017) Platinum group metal compounds in cancer chemotherapy. Johns Matthey Technol Rev 61:52–59CrossRef Barnard C (2017) Platinum group metal compounds in cancer chemotherapy. Johns Matthey Technol Rev 61:52–59CrossRef
24.
go back to reference Desoize B (2004) Metals and metal compounds in cancer treatment. Anticancer Res 24(3A):1529–1544PubMed Desoize B (2004) Metals and metal compounds in cancer treatment. Anticancer Res 24(3A):1529–1544PubMed
25.
go back to reference Bao L et al (2015) Induction of autophagy contributes to cisplatin resistance in human ovarian cancer cells. Mol Med Rep 11(1):91–98CrossRef Bao L et al (2015) Induction of autophagy contributes to cisplatin resistance in human ovarian cancer cells. Mol Med Rep 11(1):91–98CrossRef
26.
go back to reference Li X et al (2019) Autophagy: a novel mechanism of chemoresistance in cancers. Biomed Pharmacother 119:109415CrossRef Li X et al (2019) Autophagy: a novel mechanism of chemoresistance in cancers. Biomed Pharmacother 119:109415CrossRef
27.
go back to reference de Freitas LM, Soares CP, Fontana CR (2014) Synergistic effect of photodynamic therapy and cisplatin: a novel approach for cervical cancer. J Photochem Photobiol B Biol 140:365–373CrossRef de Freitas LM, Soares CP, Fontana CR (2014) Synergistic effect of photodynamic therapy and cisplatin: a novel approach for cervical cancer. J Photochem Photobiol B Biol 140:365–373CrossRef
28.
go back to reference Postiglione I, Chiaviello A, Palumbo G (2011) Enhancing photodynamyc therapy efficacy by combination therapy: dated, current and oncoming strategies. Cancers 3(2):2597–2629CrossRef Postiglione I, Chiaviello A, Palumbo G (2011) Enhancing photodynamyc therapy efficacy by combination therapy: dated, current and oncoming strategies. Cancers 3(2):2597–2629CrossRef
29.
go back to reference Hosseinabadi OK et al (2020) Benign prostatic hyperplasia treatment using plasmonic nanoparticles irradiated by laser in a rat model. Biomed Pharmacother 127:110118CrossRef Hosseinabadi OK et al (2020) Benign prostatic hyperplasia treatment using plasmonic nanoparticles irradiated by laser in a rat model. Biomed Pharmacother 127:110118CrossRef
30.
go back to reference Zafari J et al (2020) Investigation into the effect of photodynamic therapy and cisplatin on the cervical cancer cell line (A2780). J Lasers Med Sci 11(4 Suppl.):S85–S91CrossRef Zafari J et al (2020) Investigation into the effect of photodynamic therapy and cisplatin on the cervical cancer cell line (A2780). J Lasers Med Sci 11(4 Suppl.):S85–S91CrossRef
31.
go back to reference Crescenzi E et al (2004) Photodynamic therapy with indocyanine green complements and enhances low-dose cisplatin cytotoxicity in MCF-7 breast cancer cells. Mol Cancer Ther 3(5):537–544PubMed Crescenzi E et al (2004) Photodynamic therapy with indocyanine green complements and enhances low-dose cisplatin cytotoxicity in MCF-7 breast cancer cells. Mol Cancer Ther 3(5):537–544PubMed
32.
go back to reference Ge R et al (2011) An in vitro and in vivo study of combination therapy with Photogem®-mediated photodynamic therapy and cisplatin on mouse cancer cells (CT-26). Photomed Laser Surg 29(3):155–160CrossRef Ge R et al (2011) An in vitro and in vivo study of combination therapy with Photogem®-mediated photodynamic therapy and cisplatin on mouse cancer cells (CT-26). Photomed Laser Surg 29(3):155–160CrossRef
Metadata
Title
Combination of cisplatin treatment and photodynamic therapy attenuates cisplatin-induced cell toxicity in A2780 and A2780-CP cervical cancer cell lines
Authors
Fatemeh Javani Jouni
Vahideh Abdollahi
Shahrzad Zadehmodarres
Hossein Abbasinia
Mohammad Asnaashari
Jaber Zafari
Publication date
01-03-2022
Publisher
Springer London
Published in
Lasers in Medical Science / Issue 2/2022
Print ISSN: 0268-8921
Electronic ISSN: 1435-604X
DOI
https://doi.org/10.1007/s10103-021-03369-z

Other articles of this Issue 2/2022

Lasers in Medical Science 2/2022 Go to the issue